Five things for pharma marketers to know: Thursday, July 9, 2020
Coronavirus cases in U.S. pass 3 million; Walgreens partners with VillageMD; Biogen submits Alzheimer’s drug for FDA approval.
FDA
FDA app allows doctors to share real-world COVID-19 information
The CureID app is also collaborating with the WHO and the Infectious Disease Society of America.
FDA cracks down on online retailers selling scam COVID-19 treatments
The Food and Drug Administration has issued warning letters in recent weeks to websites selling scam COVID-19 treatments.
FDA partners with Aetion to gather real-world data on the coronavirus
The FDA continues its investment in real-world data with this partnership.
Hydroxychloroquine, remdesivir and Trump’s Lysol moment: How science gets done in a pandemic
Trump’s comments about household disinfectant and his hydroxychloroquine hype underscore how the risk-benefit equation for drugs is being tested during the health crisis.
A look at emergency use authorizations during COVID-19
Four treatments have been granted the emergency use authorization.
Telehealth rules relaxed, but patients still face barriers
The government has relaxed telehealth rules as most people stay home to help flatten the curve, but patients still face barriers for virtual visits.
FDA drug reviews chug along during coronavirus, but for how long?
The FDA said drug and device reviews are continuing at the normal rate, but warned that may not be able to continue indefinitely as the pandemic drags on.
Coronavirus isn’t the only thing on FDA’s mind
Drugs are still being approved and reports are still churning out, all while the FDA battles the COVID-19 outbreak.
FDA and CDC promote telemedicine during COVID-19 outbreak
The federal health agencies have taken steps to provide better telemedicine services during the outbreak.
